6Sandra M,Jensen Adi F,Gazdar F C,et al.A comparison of synaptophysin,chromogranin,and L-Dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer lines[J].Cancer Rese,1990,50(15):6068
7Charles G,Moertei MD,Larry K,et al.Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin[J].Cancer,1991,68(15):227
8Mitry E,Baudin E,Ducreux M,et al.Treatment of poorly differentiated neuroendocrine tuomurs with etoposide and cisplatin[J].Br J Cancer ,1999,81(8):1351
9Marie-Louise H,Fjǎllskog MD,Dan PK,et al.Treatment with cisplatin and etoposide in patients with neuroendocrine tumors[J].Cancer,2001,92(5):1101.
10Gosney JR, Pulmonary Endocrine Pathology-endocrine cells and endocrine tumors of the lung Butterworth-Heinemann, Ltd. Qxford,1992,1
8Ishida G M, Kato N, Hayasaka T, et al. Small cell neuroendocrine carcinomas of the uterine cervix: a his tological, immunohistochemical, arid molecular genet ic study[J]. Gynecol Pathol, 2004, 23:366-372.
9Kawase A, Nagai K. Treatment strategy for neuroen-docrine carcinoma of the lung [J]. Gan To Kagaku Ryoho, 2009,36 (10) : 1019-1022.
10Fjallskog M h,Granberg D P,Welin S I.,et al. Treat ment with cisplatin and etoposide in patients with neu roendocrine tumors [J]. Cancer, 2001 , 92 ( 5 ) : 1101 1107.
